• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏脂肪综合征概念的确立与脂联素的发现。

Establishment of a concept of visceral fat syndrome and discovery of adiponectin.

机构信息

Sumitomo Hospital.

出版信息

Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(2):131-41. doi: 10.2183/pjab.86.131.

DOI:10.2183/pjab.86.131
PMID:20154470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3417563/
Abstract

Although obesity is a major background of life style-related diseases such as diabetes mellitus, lipid disorder, hypertension and cardiovascular disease, the extent of whole body fat accumulation does not necessarily the determinant for the occurrence of these diseases. We developed the method for body fat analysis using CT scan and established the concept of visceral fat obesity, in other word metabolic syndrome in which intra-abdominal visceral fat accumulation has an important role in the development of diabetes, lipid disorder, hypertension and atherosclerosis. In order to clarify the mechanism that visceral fat accumulation causes metabolic and cardiovascular diseases, we have analyzed gene expression profile in subcutaneous adipose tissue and visceral adipose tissue. From the analysis, we found that adipose tissue, especially visceral adipose tissue expressed abundantly the genes encoding bioactive substances such as cytokines, growth factors and complements. In addition to known bioactive substances, we found a novel collagen-like protein which we named adiponectin. Adiponectin is present in plasma at a very high concentration and is inversely associated with visceral fat accumulation. Adiponectin has anti-diabetic, anti-hypertensive and anti-atherogenic properties and recent studies revealed that this protein has an anti-inflammatory and anti-oncogenic function. Therefore hypoadiponectinemia induced by visceral fat accumulation should become a strong risk factor for metabolic and cardiovascular diseases and also some kinds of cancers.In this review article, I would like to discuss the mechanism of life style-related diseases by focusing on the dysregulation of adiponectin related to obesity, especially visceral obesity.

摘要

尽管肥胖是糖尿病、脂质紊乱、高血压和心血管疾病等与生活方式相关疾病的主要背景,但全身脂肪积累的程度并不一定是这些疾病发生的决定因素。我们开发了使用 CT 扫描进行体脂分析的方法,并建立了内脏脂肪肥胖的概念,换句话说,代谢综合征中,腹部内脏脂肪积累在糖尿病、脂质紊乱、高血压和动脉粥样硬化的发展中起着重要作用。为了阐明内脏脂肪积累导致代谢和心血管疾病的机制,我们分析了皮下脂肪组织和内脏脂肪组织中的基因表达谱。从分析中,我们发现脂肪组织,特别是内脏脂肪组织,大量表达细胞因子、生长因子和补体等生物活性物质的编码基因。除了已知的生物活性物质外,我们还发现了一种新型胶原样蛋白,我们将其命名为脂联素。脂联素在血浆中以非常高的浓度存在,与内脏脂肪积累呈负相关。脂联素有抗糖尿病、抗高血压和抗动脉粥样硬化作用,最近的研究表明,这种蛋白质具有抗炎和抗癌作用。因此,内脏脂肪积累引起的脂联素减少应该成为代谢和心血管疾病以及某些癌症的强烈危险因素。在这篇综述文章中,我想通过关注与肥胖相关的脂联素的失调来讨论生活方式相关疾病的机制,特别是内脏肥胖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/f58e8b4e9500/pjab-86-131-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/435ffa2c0b6d/pjab-86-131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/68878adb9921/pjab-86-131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/27a8e0dfbfa1/pjab-86-131-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/ec069c4963da/pjab-86-131-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/3fcfefb20ad2/pjab-86-131-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/060aba19ddc8/pjab-86-131-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/eb0d3b157cf5/pjab-86-131-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/2d5ed9a982a5/pjab-86-131-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/45ddaf82d6f3/pjab-86-131-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/f58e8b4e9500/pjab-86-131-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/435ffa2c0b6d/pjab-86-131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/68878adb9921/pjab-86-131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/27a8e0dfbfa1/pjab-86-131-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/ec069c4963da/pjab-86-131-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/3fcfefb20ad2/pjab-86-131-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/060aba19ddc8/pjab-86-131-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/eb0d3b157cf5/pjab-86-131-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/2d5ed9a982a5/pjab-86-131-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/45ddaf82d6f3/pjab-86-131-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8849/3417563/f58e8b4e9500/pjab-86-131-g010.jpg

相似文献

1
Establishment of a concept of visceral fat syndrome and discovery of adiponectin.内脏脂肪综合征概念的确立与脂联素的发现。
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(2):131-41. doi: 10.2183/pjab.86.131.
2
Adiponectin: a key player in obesity related disorders.脂联素:肥胖相关疾病的关键因素。
Curr Pharm Des. 2010 Jun;16(17):1896-901. doi: 10.2174/138161210791208893.
3
The role of fat topology in the risk of disease.脂肪拓扑结构在疾病风险中的作用。
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S83-92. doi: 10.1038/ijo.2008.243.
4
Pathophysiological significance of adiponectin.脂联素的病理生理意义。
Med Mol Morphol. 2007 Jun;40(2):55-67. doi: 10.1007/s00795-007-0366-7. Epub 2007 Jun 18.
5
Cardiovascular risk of adipokines: a review.脂肪因子的心血管风险:综述
J Int Med Res. 2018 Jun;46(6):2082-2095. doi: 10.1177/0300060517706578. Epub 2017 Sep 25.
6
The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism.代谢综合征概念:内脏脂肪堆积的贡献及其分子机制。
J Atheroscler Thromb. 2011;18(8):629-39. doi: 10.5551/jat.7922. Epub 2011 Jul 8.
7
[Metabolic syndrome and visceral fat in women with cardiovascular risk factor].[具有心血管危险因素的女性的代谢综合征与内脏脂肪]
Nutr Hosp. 2017 Jul 28;34(4):863-868. doi: 10.20960/nh.1085.
8
The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity.血浆脂联素与良好的脂质谱、炎症减轻及异位脂肪堆积减少之间的关系取决于肥胖程度。
Clin Chem. 2006 Oct;52(10):1934-42. doi: 10.1373/clinchem.2006.067397. Epub 2006 Aug 17.
9
The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions.脂联素在心脏代谢疾病中的作用:营养干预的影响。
J Nutr. 2016 Feb;146(2):422S-426S. doi: 10.3945/jn.114.202432. Epub 2016 Jan 13.
10
The metabolic syndrome and adipocytokines.代谢综合征与脂肪细胞因子
FEBS Lett. 2006 May 22;580(12):2917-21. doi: 10.1016/j.febslet.2006.04.028. Epub 2006 Apr 21.

引用本文的文献

1
Exploring the Relationship Between Adipocytokines and Endometrial Cancer: Identifying Correlations With Clinico-Pathological Prognostic Factors.探索脂肪细胞因子与子宫内膜癌之间的关系:确定与临床病理预后因素的相关性。
Cancer Med. 2025 Jul;14(13):e71007. doi: 10.1002/cam4.71007.
2
The Role of Adiponectin and Variation in Metabolic Syndrome: A Narrative Review.脂联素的作用与代谢综合征的变异:一篇叙述性综述
Genes (Basel). 2025 Jun 10;16(6):699. doi: 10.3390/genes16060699.
3
The association between android-to-gynoid lean mass ratio and all-cause and specific-cause mortality in US adults: A prospective study.

本文引用的文献

1
[Sexual differentiation; Factor determining forms of obesity].[性别分化;决定肥胖类型的因素]
Presse Med (1893). 1947 May 24;55(30):339.
2
Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.治疗洞察:代谢综合征及相关心血管疾病中的脂肪细胞因子
Nat Clin Pract Cardiovasc Med. 2006 Jan;3(1):35-42. doi: 10.1038/ncpcardio0380.
3
Adipocytokines and metabolic syndrome.脂肪细胞因子与代谢综合征。
美国成年人腹部与臀部瘦体重比值与全因死亡率及特定病因死亡率之间的关联:一项前瞻性研究。
Diabetes Obes Metab. 2025 Feb;27(2):595-605. doi: 10.1111/dom.16051. Epub 2024 Nov 7.
4
Association between visceral adiposity index, lipid accumulation product and type 2 diabetes mellitus in US adults with hypertension: a cross-sectional analysis of NHANES from 2005 to 2018.美国高血压成年人内脏脂肪指数、脂联素与 2 型糖尿病的相关性:2005 年至 2018 年 NHANES 的横断面分析。
BMC Endocr Disord. 2024 Oct 15;24(1):216. doi: 10.1186/s12902-024-01750-x.
5
Clinical value and mechanistic analysis of HIIT on modulating risk and symptoms of depression: A systematic review.高强度间歇训练对调节抑郁症风险和症状的临床价值及机制分析:一项系统综述
Int J Clin Health Psychol. 2024 Jan-Mar;24(1):100433. doi: 10.1016/j.ijchp.2023.100433. Epub 2024 Jan 9.
6
The neglected association between central obesity markers and abdominal aortic aneurysm presence: A systematic review and meta-analysis.中心性肥胖标志物与腹主动脉瘤存在之间被忽视的关联:一项系统评价与荟萃分析。
Front Cardiovasc Med. 2023 Feb 9;10:1044560. doi: 10.3389/fcvm.2023.1044560. eCollection 2023.
7
Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review.银屑病与非酒精性脂肪性肝病发病机制的研究进展。
Semin Arthritis Rheum. 2023 Apr;59:152165. doi: 10.1016/j.semarthrit.2023.152165. Epub 2023 Jan 18.
8
Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia.家族性高胆固醇血症患者心血管风险预测指标与超重及肥胖的相关性
Front Cardiovasc Med. 2022 Nov 28;9:1026243. doi: 10.3389/fcvm.2022.1026243. eCollection 2022.
9
The Demographic Specific Abdominal Fat Composition and Distribution Trends in US Adults from 2011 to 2018.2011 至 2018 年美国成年人腹部脂肪组成和分布的人口统计学特征趋势。
Int J Environ Res Public Health. 2022 Sep 24;19(19):12103. doi: 10.3390/ijerph191912103.
10
The neutral amino acid transporter SLC7A10 in adipose tissue, obesity and insulin resistance.脂肪组织、肥胖与胰岛素抵抗中的中性氨基酸转运体SLC7A10
Front Cell Dev Biol. 2022 Sep 12;10:974338. doi: 10.3389/fcell.2022.974338. eCollection 2022.
Semin Vasc Med. 2005 Feb;5(1):34-9. doi: 10.1055/s-2005-871744.
4
Adiponectin-mediated modulation of hypertrophic signals in the heart.脂联素介导的心脏肥厚信号调节。
Nat Med. 2004 Dec;10(12):1384-9. doi: 10.1038/nm1137. Epub 2004 Nov 21.
5
T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.T-钙黏蛋白是六聚体和高分子量形式的Acrp30/脂联素的受体。
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10308-13. doi: 10.1073/pnas.0403382101. Epub 2004 Jun 21.
6
Hypoadiponectinemia is an independent risk factor for hypertension.低脂联素血症是高血压的独立危险因素。
Hypertension. 2004 Jun;43(6):1318-23. doi: 10.1161/01.HYP.0000129281.03801.4b. Epub 2004 May 3.
7
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages.脂联素通过人巨噬细胞中白细胞介素-10的表达特异性增加金属蛋白酶组织抑制剂-1。
Circulation. 2004 May 4;109(17):2046-9. doi: 10.1161/01.CIR.0000127953.98131.ED. Epub 2004 Apr 19.
8
Plasma adiponectin levels and risk of myocardial infarction in men.男性血浆脂联素水平与心肌梗死风险
JAMA. 2004 Apr 14;291(14):1730-7. doi: 10.1001/jama.291.14.1730.
9
Association of hypoadiponectinemia with impaired vasoreactivity.低脂联素血症与血管反应性受损的关联。
Hypertension. 2003 Sep;42(3):231-4. doi: 10.1161/01.HYP.0000083488.67550.B8. Epub 2003 Jul 14.
10
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.介导抗糖尿病代谢效应的脂联素受体的克隆
Nature. 2003 Jun 12;423(6941):762-9. doi: 10.1038/nature01705.